UniProt | Protein Name |
---|---|
P29965 |
|
GO Term | Evidence Code | PMID |
---|---|---|
positive regulation of interleukin-4 production | ||
positive regulation of extrinsic apoptotic signaling pathway | ||
cell surface receptor signaling pathway | ||
isotype switching | ||
B cell proliferation |
GO Term | Evidence Code | PMID |
---|---|---|
external side of plasma membrane | ||
membrane | ||
Golgi apparatus | ||
plasma membrane | ||
cell surface |
GO Term | Evidence Code | PMID |
---|---|---|
protein binding | ||
integrin binding | ||
tumor necrosis factor receptor binding | ||
cytokine activity | ||
protein serine/threonine kinase activator activity |
Gene Ontology |
---|
CD40 receptor binding |
cytokine activity |
immune response |
tumor necrosis factor receptor binding |
InterPro |
---|
CD40 ligand |
Tumour necrosis factor domain |
Tumour necrosis factor, conserved site |
Tumour necrosis factor-like domain superfamily |
DO ID | Disease Name | Source |
---|---|---|
DOID:0050169 | cutaneous lupus erythematosus | |
DOID:0050175 | tick-borne encephalitis | |
DOID:0050185 | erythema multiforme | |
DOID:0050589 | inflammatory bowel disease | |
DOID:0050731 | vitamin B12 deficiency | |
DOID:0050873 | follicular lymphoma | |
DOID:0060022 | CD40 ligand deficiency | |
DOID:0060903 | thrombosis | |
DOID:0070355 | overactive bladder syndrome | |
DOID:0080162 | lupus nephritis |
Species | Gene ID | OrthoDB | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|---|
21947 | MGI:88337 | MOUSE65790 | ||
84349 | RGD:708418 | RATNO45432 | ||
282387 | BOVIN36368 | |||
397231 | PIGXX38107 | |||
403468 | CANLF20199 | |||
473802 | 9598_0:005805 | PANTR46898 | ||
493850 | FELCA39097 | |||
574160 | MACMU47590 | |||
767628 | SHEEP20082 | |||
793819 | ZFIN:ZDB-GENE-100727-1 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024